Youming Zhang
Direttore/Membro del Consiglio presso FUFENG GROUP LIMITED
Posizioni attive di Youming Zhang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FUFENG GROUP LIMITED | Direttore/Membro del Consiglio | 01/04/2021 | - |
| Independent Dir/Board Member | 01/04/2021 | - | |
| Shandong University | Corporate Officer/Principal | - | - |
Storia della carriera di Youming Zhang
Precedenti posizioni note di Youming Zhang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Gene Bridges GmbH
 Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Direttore Tecnico/Scientifico/R&S | - | 01/01/2013 |
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - | - |
Formazione di Youming Zhang
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Xiamen University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistiche
Distribuzione geografica
| Cina | 5 |
| Germania | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 6 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FUFENG GROUP LIMITED | Consumer Non-Durables |
| Aziende private | 1 |
|---|---|
Gene Bridges GmbH
Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
- Borsa valori
- Insiders
- Youming Zhang
- Esperienza
